Certified by Founder Lodge
CellVoyant
United Kingdom - Bristol, England
START UP
1 Disclosed Funding Rounds $9,644,590
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
CellVoyant is an AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases. Our technology uses AI-first live cell imaging to predict and op
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 27 ,2024 | Seed | $9,644,590 |
Air Street Capital
Octopus Ventures
Horizons Ventures
Verve Ventures
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
